Sun Pharmaceutical Industries524715New rating assigned
CRISIL and ICRA assign AAA to Sun Pharma's Rs.15000 crore proposed NCDs; AAA/A1+ facilities reaffirmed
By ScoutQuest · · 1 min read
Rs 15,300 croreOperating income, first quarter of fiscal
Non-convertible debentures ratedRs.15000 Crore
Total bank loan facilities rated by CRISILRs.176 Crore
ICRA-rated short-term facilities of Sun Pharma LaboratoriesINR 150 crore
- NCD Programme Size
- Rs.15000 crore NCD programme
- CRISIL Rating
- Crisil AAA/Stable assigned to NCDs; Crisil AAA/Stable and Crisil A1+ reaffirmed
- ICRA Rating
- [ICRA]AAA (Stable) assigned; [ICRA]A1+ reaffirmed
- Agency
- CRISIL Ratings and ICRA
- Action
- Assigned
CRISIL and ICRA assign AAA to Sun Pharma's Rs.15000 crore proposed NCDs; AAA/A1+ facilities reaffirmed.
CRISIL AAAAssigned · CRISIL Ratings and ICRA
Organon acquisition announcement proposed acquisition of Organon & Co.
Rating action date
Also from Sun Pharmaceutical Industries
Sun Pharma to present long-term UNLOXCYT data in advanced CSCC at ESMO 2026
23 Oct 2026
UNLOXCYT elevated to NCCN Category 2A option for locally advanced CSCC
20 Oct 2026
Sun Pharma to announce Q2 results on 30 October 2026; earnings call at 6:30 pm IST
15 Oct 2026
More numbers
- Total bank loan facilities rated by CRISILRs.176 Crore
- Proposed non-convertible debentures ratedRs.15000 Crore
- Commercial paper programme ratedRs.4000 Crore
- ICRA-rated short-term facilities of Sun Pharma LaboratoriesINR 150 crore
- Operating income, first quarter of fiscal 2027Rs 15,300 crore
- Consolidated revenue, fiscal 202658,563 (Rs crore)
Source: BSE · 13 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.